Chirurgie der Speiseröhre

Al-Sarraf M, Martz K, Herskovic A, et al.: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study.

Journal of Clinical Oncology 15(1): 277-284, 1997.

Bourke MJ, Hope RL, Chu G, et al.: Laser palliation of inoperable malignant dysphagia: initial and at death.

Gastrointestinal Endoscopy 43(1): 29-32, 1996.

Bourke MJ, Hope RL, Chu G, et al.: Laser palliation of inoperable malignant dysphagia: initial and at death.

Gastrointestinal Endoscopy 43(1): 29-32, 1996.

Campbell WR, Taylor SA, Pierce GE, et. al.: Therapeutic alternatives in patients with esophageal cancer.

American Journal of Surgery 150(6): 665-668, 1985.

Coia LR, Engstrom PF, Paul AR, et al.: Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma.

International Journal of Radiation Oncology, Biology, Physics 20(1): 29-36, 1991.

Ellis FH Jr, Williamson WA, Heatley GJ: Cancer of the esophagus and cardia: does age influence treatment selection and surgical outcomes ?

Journal of the American College of Surgeons 187(4): 345-351, 1998.

Fleischer D, Sivak MV: Endoscopic Nd-YAG laser therapy as palliation for esophagogastric cancer: parameters affecting initial outcome.

Gastroenterology 89(4): 827-831, 1985.

Gaspar LE, Nag S, Herskovic A, et al.: American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer.

International Journal of Radiation Oncology, Biology, Physics 38(1): 127-132, 1997.

Heier SK, Heier LM: Tissue sensitizers.

Gastrointestinal Endoscopy Clinics of North America 4(2): 327-252, 1994.

Herskovic A, Al-Sarraf M: Combination of 5-fluorouracil and radiation in esophageal cancer.

Seminars in Radiation Oncology 7(4): 283-290, 1997.

Herskovic A, Martz K, Al-Sarraf M, et al.: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

New England Journal of Medicine 326(24): 1593-1598, 1992.

Izbicki JR, Hosch SB, Pichlmeier U, Rehders A, Busch C, Niendorf A, Passlick B, Broelsch CE, Pantel K Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer.

N Engl J Med 1997 Oct 23;337(17):1188-94.

Karlin DA, Fisher RS, Krevsky B: Prolonged survival and effective palliation in patients with squamous cell carcinoma of the esophagus following endoscopic laser therapy.

Cancer 59(11): 1969-1972, 1987.

Kelsen DP, Bains M, Burt M: Neoadjuvant chemotherapy and surgery of cancer of the esophagus.

Seminars in Surgical Oncology 6(5): 268-273, 1990.

Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.

N Engl J Med 1998 Dec 31;339(27):1979-84.

Korst RJ, Rusch VW, Venkatraman E, et al.: Proposed revision of the staging classification for esophageal cancer.

Journal of Thoracic and Cardiovascular Surgery 115(3): 660-670, 1998.

Kubba AK: Role of photodynamic therapy in the management of gastrointestinal cancer.

Digestion 60(1): 1-10, 1999.

Lightdale CJ, Heier SK, Marcon NE, et al.: Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial.the management of gastrointestinal cancer.

Gastrointestinal Endoscopy 42(6): 507-512, 1995.

Mellow MH, Pinkas H: Endoscopic therapy for esophageal carcinoma with Nd:Yag laser: prospective evaluation of efficacy, complications, and survival.the management of gastrointestinal cancer.

Gastrointestinal Endoscopy 30(6): 334-339, 1984.

Patti MG, Arcerito M, Feo CV, Worth S, De Pinto M, Gibbs VC, Gantert W, Tyrrell D, Ferrell LF, Way LW Barrett's Esophagus: A Surgical Disease.the management of gastrointestinal cancer.

J Gastrointest Surg 1999 Jul;3(4):397-404.

Patti MG, Corvera CU, Glasgow RE, Way LW A hospital's annual rate of esophagectomy influences the operative mortality rate.the management of gastrointestinal cancer.

J Gastrointest Surg 1998 Mar-Apr;2(2):186-92.

Saxon RR, Morrison KE, Lakin PC, et al.: Malignant esophageal obstruction and esophagorespiratory fistula: palliation with a polyethylene-covered Z-stent.the management of gastrointestinal cancer.

Radiology 202(2): 349-354, 1997.

Sur RK, Donde B, Levin VC, et al.: Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer.the management of gastrointestinal cancer.

International Journal of Radiation Oncology, Biology, Physics 40(2): 447-453, 1998.

Tietjen TG, Pasricha PJ, Kalloo AN: Management of malignant esophageal stricture with esophageal dilation and esophageal stents.the management of gastrointestinal cancer.

Gastrointestinal Endoscopy Clinics of North America 4(4): 851-862, 1994.

Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP A comparison of multimodal therapy and surgery for esophageal adenocarcinoma .the management of gastrointestinal cancer.

N Engl J Med 1996 Aug 15;335(7):462-7.